Patents Assigned to TRIA BIOSCIENCE CORP.
  • Patent number: 10111948
    Abstract: The present disclosure relates to peptide monomers comprising an amphipathic ?-helical peptide, and optionally, at least one T cell epitope peptide; and to dimers and trimers comprising the peptide monomers. The monomeric, dimeric, and trimeric peptides may be conjugated to at least one hapten, wherein the hapten is linked to a lysine or aspartic acid residue of the peptide monomer. These peptide conjugates are useful as vaccine delivery vehicles.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: October 30, 2018
    Assignee: TRIA BIOSCIENCE CORP.
    Inventors: Christopher H. Clegg, Keith D. Miller